Hemophilia Gene Therapy: Approaching the First Licensed Product
The clinical potential of hemophilia gene therapy has now been pursued for the past 30 years, and there is a realistic expectation that this goal will be achieved within the next couple of years with the licensing of a gene therapy product. While recent late phase clinical trials of hemophilia gene...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2021-03-01
|
| Serie: | HemaSphere |
| Accesso online: | http://journals.lww.com/10.1097/HS9.0000000000000540 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|